Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Cancer With Metastases to the Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT06283134
What this trial is testing

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
China Medical University, China 60
Testing effectiveness (Phase 2)Study completedNCT00645710
What this trial is testing

Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery

Who this might be right for
Liver MetastasesRecurrent Colon CancerRecurrent Rectal Cancer+2 more
City of Hope Medical Center 16
Early research (Phase 1)Active Not RecruitingNCT03821935
What this trial is testing

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 364
Testing effectiveness (Phase 2)Looking for participantsNCT06225843
What this trial is testing

Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis

Who this might be right for
Metastatic Colorectal Cancer
Alethia Biotherapeutics 17
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT05240950
What this trial is testing

Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases

Who this might be right for
Colorectal CancerMetastatic Liver Cancer
Changhai Hospital 18
Early research (Phase 1)Active Not RecruitingNCT04046445
What this trial is testing

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal CancerMSSStage IV Colon Cancer+3 more
Amal Therapeutics 96
Large-scale testing (Phase 3)Looking for participantsNCT05863195
What this trial is testing

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8+1 more
ECOG-ACRIN Cancer Research Group 408
Early research (Phase 1)Ended earlyNCT00072098
What this trial is testing

Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Max Sung 22
Testing effectiveness (Phase 2)UnknownNCT00997685
What this trial is testing

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

Who this might be right for
Potentially Resectable Liver Metastasis From CRCColorectal Cancer
Guangdong Provincial People's Hospital 110
Testing effectiveness (Phase 2)Study completedNCT02350530
What this trial is testing

FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 138
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Testing effectiveness (Phase 2)Looking for participantsNCT03401294
What this trial is testing

Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
University of Saskatchewan 32
Testing effectiveness (Phase 2)Study completedNCT00557102
What this trial is testing

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute, France 24
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT05775146
What this trial is testing

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastasis Colon Cancer
AHS Cancer Control Alberta 24
Testing effectiveness (Phase 2)UnknownNCT01949194
What this trial is testing

Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers

Who this might be right for
Metastatic Colorectal Cancer
Gerald Batist 48
Testing effectiveness (Phase 2)Study completedNCT02063529
What this trial is testing

FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 101
Testing effectiveness (Phase 2)Study completedNCT00700570
What this trial is testing

Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 45
Next Page